These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32737955)

  • 1. Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances.
    Mastrangelopoulou M; Grigalavicius M; Raabe TH; Skarpen E; Juzenas P; Peng Q; Berg K; Theodossiou TA
    Cancer Rep (Hoboken); 2022 Dec; 5(12):e1278. PubMed ID: 32737955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
    Mansi M; Howley R; Chandratre S; Chen B
    Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
    Mansi M; Howley R; Chen B
    Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
    Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
    J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
    Howley R; Mansi M; Shinde J; Restrepo J; Chen B
    J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
    Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
    Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
    Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
    Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
    J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
    Chandratre S; Olsen J; Howley R; Chen B
    Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
    Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
    Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
    Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
    Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
    J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
    Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
    Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
    Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres.
    Park J; Oh SJ; Shim JK; Ji YB; Moon JH; Kim EH; Huh YM; Suh JS; Chang JH; Lee SJ; Kang SG
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4391-4402. PubMed ID: 36107247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic efficacy of photodynamic therapy on female hormonal-dependent cancers in a hormonal simulated microenvironment.
    Chu ES; Wu RW; Huang Z
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103998. PubMed ID: 38316340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
    Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.